Floatz logo

Tirzepatide

Chronic Inflammation

University of Hawaiiprotein_peptidePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Chronic Inflammation cohort.

Asset / SponsorPhaseRating
Semaglutide
University of Colorado, Denver
Phase 4BB
Maolactin
RDC Clinical Pty Ltd
Phase 3BB
Maltodextrin
RDC Clinical Pty Ltd
Phase 3BB
PREDNISONE TABLETS
Minneapolis Veterans Affairs Medical Center
Phase 2B

Same molecule, other indications

Tirzepatide is also rated in:

type 1 diabetes mellitusDormant
BBB
Indicative ·
78 / 100
View asset →
psoriatic arthritisDormant
BBB
Indicative ·
74 / 100
View asset →
diastolic heart failureDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →